Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Investing Activities (2016 - 2025)

Sonoma Pharmaceuticals has reported Cash from Investing Activities over the past 16 years, most recently at -$47000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 2250.0% year-over-year to -$47000.0; the TTM value through Dec 2025 reached -$210000.0, down 1300.0%, while the annual FY2025 figure was -$80000.0, 3900.0% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$47000.0 at Sonoma Pharmaceuticals, down from -$10000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $34000.0 in Q4 2022 and troughed at -$187000.0 in Q3 2022.
  • A 5-year average of -$31894.7 and a median of -$17000.0 in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 121.95% in 2024 and later plummeted 2250.0% in 2025.
  • Year by year, Cash from Investing Activities stood at $11000.0 in 2021, then surged by 209.09% to $34000.0 in 2022, then plummeted by 102.94% to -$1000.0 in 2023, then tumbled by 100.0% to -$2000.0 in 2024, then plummeted by 2250.0% to -$47000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for SNOA at -$47000.0 in Q4 2025, -$10000.0 in Q3 2025, and -$106000.0 in Q2 2025.